FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128304818> ?p ?o ?g. }

• W3128304818 endingPage "1501" @default.
• W3128304818 startingPage "1494" @default.
• W3128304818 abstract "Few biomarkers to evaluate pathophysiological changes in extra-cardiac tissues have been identified in patients with heart failure (HF). Fatty acid-binding protein 1 (FABP), also known as liver FABP, is predominantly expressed in the liver. Circulating FABP1 has been proposed to be a sensitive biomarker for liver injury. However, little is known about the potential role of FABP1 as a biomarker for HF.Measurements of serum FABP1 and echocardiography were performed in subjects with compensated HF (n = 162) and control subjects without HF (n = 20). Patients were prospectively followed-up for a composite outcome of all-cause mortality or HF hospitalization. Compared with control subjects, levels of FABP1 were elevated in HF patients [7.9 (6.4-11.7) vs. 17.6 (10.4-28.9) ng/mL, P < 0.0001]. There were significant correlations between FABP1 levels and estimated right ventricular systolic pressure and right atrial pressure. During a median follow-up of 12.0 months, there were 55 primary composite endpoints in the HF cohort. The highest FABP1 tertile was associated with a three-fold increased risk of the composite outcome compared with the lowest tertile [95% confidence interval (1.46-6.68), P = 0.003], but other conventional hepatobiliary markers did not predict the outcome. After adjusting for age, sex, atrial fibrillation, and N-terminal pro-B-type natriuretic peptide levels, serum FABP1 remained independently associated with the outcome. Adding FABP1 to the model based on clinical factors and N-terminal pro-B-type natriuretic peptide significantly improved the prognostic value (global χ2 20.8 vs. 15.5, P = 0.01).Serum FABP1 levels are elevated in compensated HF patients, and the magnitude of elevation is independently associated with pulmonary hypertension, right atrial hypertension, and worse clinical outcomes. FABP1 may serve as a new potential biomarker for the assessment of hitherto unrecognized derangement of cardio-hepatic interaction in HF." @default.
• W3128304818 created "2021-02-15" @default.
• W3128304818 creator A5001298175 @default.
• W3128304818 creator A5006956543 @default.
• W3128304818 creator A5013599375 @default.
• W3128304818 creator A5034431570 @default.
• W3128304818 creator A5036654496 @default.
• W3128304818 creator A5037877046 @default.
• W3128304818 creator A5046598629 @default.
• W3128304818 creator A5057083316 @default.
• W3128304818 creator A5070055930 @default.
• W3128304818 creator A5072240066 @default.
• W3128304818 creator A5074976924 @default.
• W3128304818 creator A5079911250 @default.
• W3128304818 creator A5088470119 @default.
• W3128304818 date "2021-02-04" @default.
• W3128304818 modified "2023-09-27" @default.
• W3128304818 title "Prognostic impact of elevated fatty acid‐binding protein 1 in patients with heart failure" @default.
• W3128304818 cites W129855031 @default.
• W3128304818 cites W1913322942 @default.
• W3128304818 cites W1979383399 @default.
• W3128304818 cites W1992719447 @default.
• W3128304818 cites W2012034410 @default.
• W3128304818 cites W2046722666 @default.
• W3128304818 cites W2047624001 @default.
• W3128304818 cites W2050353671 @default.
• W3128304818 cites W2081438731 @default.
• W3128304818 cites W2082949183 @default.
• W3128304818 cites W2099344088 @default.
• W3128304818 cites W2118024623 @default.
• W3128304818 cites W2124624517 @default.
• W3128304818 cites W2128607084 @default.
• W3128304818 cites W2167216129 @default.
• W3128304818 cites W2481602709 @default.
• W3128304818 cites W2549803295 @default.
• W3128304818 cites W2594341951 @default.
• W3128304818 cites W2605975631 @default.
• W3128304818 cites W2745438221 @default.
• W3128304818 cites W2766290450 @default.
• W3128304818 cites W2912227678 @default.
• W3128304818 cites W2999176505 @default.
• W3128304818 cites W3003266334 @default.
• W3128304818 cites W3128304818 @default.
• W3128304818 cites W4249896096 @default.
• W3128304818 doi "https://doi.org/10.1002/ehf2.13239" @default.
• W3128304818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8006713" @default.
• W3128304818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33539661" @default.
• W3128304818 hasPublicationYear "2021" @default.
• W3128304818 type Work @default.
• W3128304818 sameAs 3128304818 @default.
• W3128304818 citedByCount "6" @default.
• W3128304818 countsByYear W31283048182021 @default.
• W3128304818 countsByYear W31283048182022 @default.
• W3128304818 countsByYear W31283048182023 @default.
• W3128304818 crossrefType "journal-article" @default.
• W3128304818 hasAuthorship W3128304818A5001298175 @default.
• W3128304818 hasAuthorship W3128304818A5006956543 @default.
• W3128304818 hasAuthorship W3128304818A5013599375 @default.
• W3128304818 hasAuthorship W3128304818A5034431570 @default.
• W3128304818 hasAuthorship W3128304818A5036654496 @default.
• W3128304818 hasAuthorship W3128304818A5037877046 @default.
• W3128304818 hasAuthorship W3128304818A5046598629 @default.
• W3128304818 hasAuthorship W3128304818A5057083316 @default.
• W3128304818 hasAuthorship W3128304818A5070055930 @default.
• W3128304818 hasAuthorship W3128304818A5072240066 @default.
• W3128304818 hasAuthorship W3128304818A5074976924 @default.
• W3128304818 hasAuthorship W3128304818A5079911250 @default.
• W3128304818 hasAuthorship W3128304818A5088470119 @default.
• W3128304818 hasBestOaLocation W31283048181 @default.
• W3128304818 hasConcept C126322002 @default.
• W3128304818 hasConcept C134018914 @default.
• W3128304818 hasConcept C164705383 @default.
• W3128304818 hasConcept C2775915353 @default.
• W3128304818 hasConcept C2778198053 @default.
• W3128304818 hasConcept C2779161974 @default.
• W3128304818 hasConcept C2781197716 @default.
• W3128304818 hasConcept C55493867 @default.
• W3128304818 hasConcept C71924100 @default.
• W3128304818 hasConcept C86803240 @default.
• W3128304818 hasConcept C90924648 @default.
• W3128304818 hasConceptScore W3128304818C126322002 @default.
• W3128304818 hasConceptScore W3128304818C134018914 @default.
• W3128304818 hasConceptScore W3128304818C164705383 @default.
• W3128304818 hasConceptScore W3128304818C2775915353 @default.
• W3128304818 hasConceptScore W3128304818C2778198053 @default.
• W3128304818 hasConceptScore W3128304818C2779161974 @default.
• W3128304818 hasConceptScore W3128304818C2781197716 @default.
• W3128304818 hasConceptScore W3128304818C55493867 @default.
• W3128304818 hasConceptScore W3128304818C71924100 @default.
• W3128304818 hasConceptScore W3128304818C86803240 @default.
• W3128304818 hasConceptScore W3128304818C90924648 @default.
• W3128304818 hasFunder F4320321852 @default.
• W3128304818 hasFunder F4320323102 @default.
• W3128304818 hasFunder F4320323467 @default.
• W3128304818 hasFunder F4320327877 @default.
• W3128304818 hasFunder F4320328054 @default.
• W3128304818 hasIssue "2" @default.
• W3128304818 hasLocation W31283048181 @default.

• next